Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Hanŭs L[au]:

Phytocannabinoids: a unified critical inventory. Hanuš LO et al. Nat Prod Rep. (2016)

Early phytocannabinoid chemistry to endocannabinoids and beyond. Mechoulam R et al. Nat Rev Neurosci. (2014)

Cannabinoids and Cytochrome P450 Interactions. Zendulka O et al. Curr Drug Metab. (2016)

Search results

Items: 1 to 50 of 81

1.

The Anti-Inflammatory Properties of Terpenoids from Cannabis.

Gallily R, Yekhtin Z, Hanuš LO.

Cannabis Cannabinoid Res. 2018 Dec 26;3(1):282-290. doi: 10.1089/can.2018.0014. eCollection 2018.

2.

Phytocannabinoids: a unified critical inventory.

Hanuš LO, Meyer SM, Muñoz E, Taglialatela-Scafati O, Appendino G.

Nat Prod Rep. 2016 Nov 23;33(12):1357-1392. Review.

PMID:
27722705
3.

Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy.

Ujváry I, Hanuš L.

Cannabis Cannabinoid Res. 2016 Mar 1;1(1):90-101. doi: 10.1089/can.2015.0012. eCollection 2016. Review.

4.

Cannabinoids and Cytochrome P450 Interactions.

Zendulka O, Dovrtělová G, Nosková K, Turjap M, Šulcová A, Hanuš L, Juřica J.

Curr Drug Metab. 2016;17(3):206-26. Review.

PMID:
26651971
5.

HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid.

Haj CG, Sumariwalla PF, Hanuš L, Kogan NM, Yektin Z, Mechoulam R, Feldmann M, Gallily R.

J Pharmacol Exp Ther. 2015 Oct;355(1):66-75. doi: 10.1124/jpet.115.226100. Epub 2015 Aug 13.

6.

HU-446 and HU-465, Derivatives of the Non-psychoactive Cannabinoid Cannabidiol, Decrease the Activation of Encephalitogenic T Cells.

Kozela E, Haj C, Hanuš L, Chourasia M, Shurki A, Juknat A, Kaushansky N, Mechoulam R, Vogel Z.

Chem Biol Drug Des. 2016 Jan;87(1):143-53. doi: 10.1111/cbdd.12637. Epub 2015 Sep 16.

PMID:
26259697
7.

Prediction of central venous catheter-related bloodstream infections (CRBSIs) in patients with haematologic malignancies using a modified Infection Probability Score (mIPS).

Schalk E, Hanus L, Färber J, Fischer T, Heidel FH.

Ann Hematol. 2015 Sep;94(9):1451-6. doi: 10.1007/s00277-015-2387-y. Epub 2015 May 3.

PMID:
25933677
8.

Hypoglycemic activity of withanolides and elicitated Withania somnifera.

Gorelick J, Rosenberg R, Smotrich A, Hanuš L, Bernstein N.

Phytochemistry. 2015 Aug;116:283-289. doi: 10.1016/j.phytochem.2015.02.029. Epub 2015 Mar 18.

PMID:
25796090
9.

Early phytocannabinoid chemistry to endocannabinoids and beyond.

Mechoulam R, Hanuš LO, Pertwee R, Howlett AC.

Nat Rev Neurosci. 2014 Nov;15(11):757-64. doi: 10.1038/nrn3811. Epub 2014 Oct 15. Review.

PMID:
25315390
10.

Inhaled medicinal cannabis and the immunocompromised patient.

Ruchlemer R, Amit-Kohn M, Raveh D, Hanuš L.

Support Care Cancer. 2015 Mar;23(3):819-22. doi: 10.1007/s00520-014-2429-3. Epub 2014 Sep 13.

PMID:
25216851
11.

N-Acyl amino acids and their impact on biological processes.

Hanuš L, Shohami E, Bab I, Mechoulam R.

Biofactors. 2014 Jul-Aug;40(4):381-8. doi: 10.1002/biof.1166. Epub 2014 Apr 21.

PMID:
24753374
12.

[Problem of end-effector of ischemic postconditioning of the heart].

Maslov LN, Naryzhnaia NV, Hanuš L, Pei JM, Baĭkov AN, Zhang I, Wang H, Khaliulin IG.

Ross Fiziol Zh Im I M Sechenova. 2013 May;99(5):555-74. Review. Russian.

PMID:
24459867
13.

[Protein kinases role in adaptive phenomenon of heart ischemic postconditioning development].

Maslov LN, Mrochek AG, Shchepetkin IA, Headrick JP, Hanus L, Barzakh EI, Lishmanov AIu, Gorbunov AS, Tsybul'nikov SIu, Baĭkov AN.

Ross Fiziol Zh Im I M Sechenova. 2013 Apr;99(4):433-52. Review. Russian.

PMID:
23862384
14.

[Adaptive phenomenon of ischemic postconditioning of the heart. Perspectives of clinical use].

Maslov LN, Mrochek AG, Khaliulin IG, Hanus L, Pei JM, Zhang Y.

Vestn Ross Akad Med Nauk. 2013;(1):10-20. Review. Russian.

PMID:
23805634
15.

[Signaling mechanism of cardioprotective effects of opioids].

Maslov LN, Hanus L, Pei J-, Krylatov AV, Naryzhnaia NV, Barzakh EI, Lishmanov AIu.

Eksp Klin Farmakol. 2013;76(3):41-8. Review. Russian.

PMID:
23767104
16.

[Perspective of creation of drugs on basis of opioids increasing cardiac tolerance to pathogenic impact of ischemia reperfusion].

Maslov LN, Lishmanov IuB, Headrick JP, Pei J-, Hanus L, Krylatov AV, Naryzhnaia NV.

Eksp Klin Farmakol. 2012;75(10):22-8. Review. Russian.

PMID:
23240155
17.

[Phenomenon of heart ischemic postconditioning].

Maslov LN, Mrochek AG, Hanus L, Pei J-, Zhang Y, Wang H, Naryzhnaia NV.

Ross Fiziol Zh Im I M Sechenova. 2012 Aug;98(8):943-61. Review. Russian.

PMID:
23155619
18.

Novel natural and synthetic ligands of the endocannabinoid system.

Hanus LO, Mechoulam R.

Curr Med Chem. 2010;17(14):1341-59. Review.

PMID:
20166928
19.

Ascaridole and related peroxides from the genus Chenopodium.

Dembitsky V, Shkrob I, Hanus LO.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008 Dec;152(2):209-15.

20.
21.

Identification of cyclopropyl fatty acids in walnut (Juglans regia L.) oil.

Hanus LO, Goldshlag P, Dembitsky VM.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008 Jun;152(1):41-5.

22.

Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids.

Hanus LO.

Med Res Rev. 2009 Mar;29(2):213-71. doi: 10.1002/med.20135. Review.

PMID:
18777572
23.

[Role of cannabinoid receptors in regulation of cardiac tolerance to ischemia and reperfusion].

Lasukova OV, Maslov LN, Ermakov SIu, Crawford D, Barth F, Krylatov AV, Hanus LO.

Izv Akad Nauk Ser Biol. 2008 Jul-Aug;(4):471-8. Russian.

PMID:
18771032
24.

Cyclobutane-containing alkaloids: origin, synthesis, and biological activities.

Sergeiko A, Poroikov VV, Hanus LO, Dembitsky VM.

Open Med Chem J. 2008 Apr 15;2:26-37. doi: 10.2174/1874104500802010026.

25.

Thymol and carvacrol production from leaves of wild Palestinian Majorana syriaca.

Abu-Lafi S, Odeh I, Dewik H, Qabajah M, Hanus LO, Dembitsky VM.

Bioresour Technol. 2008 Jun;99(9):3914-8. Epub 2007 Sep 10.

PMID:
17826989
26.

Discovery and isolation of anandamide and other endocannabinoids.

Hanus LO.

Chem Biodivers. 2007 Aug;4(8):1828-41. Review. No abstract available.

PMID:
17712821
27.

Cannabidiol--recent advances.

Mechoulam R, Peters M, Murillo-Rodriguez E, Hanus LO.

Chem Biodivers. 2007 Aug;4(8):1678-92. Review.

PMID:
17712814
28.

Natural compounds of Palestine flora. Comparison analysis by static headspace and steam distillation GC-MS of semivolatile secondary metabolites from leaves of cultivated Palestinian Majorana syriaca.

Abu-Lafi S, Odeh I, Dewik H, Qabajah M, Imam A, Dembitsky VM, Hanus LO.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007 Jun;151(1):21-9.

29.

Role of cannabinoid receptors in the regulation of cardiac contractility during ischemia/reperfusion.

Maslov LN, Lasukova OV, Krylatov AV, Hanus LO, Pertwee R, Ivanchuk II, Crowford D.

Bull Exp Biol Med. 2006 Nov;142(5):557-61.

PMID:
17415461
30.

New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity.

Ben-Shabat S, Hanus LO, Katzavian G, Gallily R.

J Med Chem. 2006 Feb 9;49(3):1113-7.

PMID:
16451075
31.

Myrrh--Commiphora chemistry.

Hanus LO, Rezanka T, Dembitsky VM, Moussaieff A.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Jun;149(1):3-27. Review.

32.

Substances isolated from Mandragora species.

Hanus LO, Rezanka T, Spízek J, Dembitsky VM.

Phytochemistry. 2005 Oct;66(20):2408-17. Epub 2005 Aug 31. Review.

PMID:
16137728
33.

Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.

Fride E, Ponde D, Breuer A, Hanus L.

Neuropharmacology. 2005 Jun;48(8):1117-29. Epub 2005 Apr 26.

PMID:
15910887
34.

Secondary metabolites of slime molds (myxomycetes).

Dembitsky VM, Rezanka T, Spízek J, Hanus LO.

Phytochemistry. 2005 Apr;66(7):747-69. Review.

PMID:
15797602
35.

Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors.

Hanus LO, Tchilibon S, Ponde DE, Breuer A, Fride E, Mechoulam R.

Org Biomol Chem. 2005 Mar 21;3(6):1116-23. Epub 2005 Feb 16.

PMID:
15750656
36.

(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only.

Fride E, Feigin C, Ponde DE, Breuer A, Hanus L, Arshavsky N, Mechoulam R.

Eur J Pharmacol. 2004 Dec 15;506(2):179-88.

PMID:
15588739
37.

The tornabeatins, four tetrahydro-2-furanone derivatives from the lichenized ascomycete Tornabea scutellifera (With.) J.R. Laundon.

Rezanka T, Temina M, Hanus L, Dembitsky VM.

Phytochemistry. 2004 Sep;65(18):2605-12.

PMID:
15451325
38.

Enteridinines A and B from slime mold Enteridium lycoperdon.

Rezanka T, Dvoráková R, Hanus LO, Dembitsky VM.

Phytochemistry. 2004 Feb;65(4):455-62.

PMID:
14759541
39.

Heteroflocculation of binary latex dispersions of similar chemistry but varying size.

Shenoy SS, Sadowsky R, Mangum JL, Hanus LH, Wagner NJ.

J Colloid Interface Sci. 2003 Dec 15;268(2):380-93.

PMID:
14643238
40.

Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain.

Hanus L, Avraham Y, Ben-Shushan D, Zolotarev O, Berry EM, Mechoulam R.

Brain Res. 2003 Sep 5;983(1-2):144-51.

PMID:
12914975
41.

Two cyclohexenone glycosides from the North American fern Woodwardia virginica (L.) Smith.

Rezanka T, Dembitsky VM, Hanus LO.

Phytochemistry. 2003 Aug;63(8):931-7.

PMID:
12895542
42.

A trinorsesterterpene glycoside from the North American fern Woodwardia virginica (L.) Smith.

Hanus LO, Rezanka T, Dembitsky VM.

Phytochemistry. 2003 Aug;63(8):869-75.

PMID:
12895532
43.

Sterol compositions of the filamentous nitrogen-fixing terrestrial cyanobacterium Scytonema sp.

Rezanka T, Dembitsky VM, Go JV, Dor I, Prell A, Hanus L.

Folia Microbiol (Praha). 2003;48(3):357-60.

PMID:
12879746
44.

Fundamentals of aggregation in concentrated dispersions: fiber-optic quasielastic light scattering and linear viscoelastic measurements.

Elliott SL, Butera RJ, Hanus LH, Wagner NJ.

Faraday Discuss. 2003;123:369-83; discussion 401-21.

PMID:
12638871
45.

Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects.

Mechoulam R, Hanus L.

Chem Phys Lipids. 2002 Dec 31;121(1-2):35-43. Review.

PMID:
12505688
46.

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.

Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V.

Br J Pharmacol. 2001 Oct;134(4):845-52.

47.

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.

Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E.

Nature. 2001 Oct 4;413(6855):527-31.

PMID:
11586361
48.

Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems.

Fedorova I, Hashimoto A, Fecik RA, Hedrick MP, Hanus LO, Boger DL, Rice KC, Basile AS.

J Pharmacol Exp Ther. 2001 Oct;299(1):332-42.

PMID:
11561096
49.

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.

Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE, Kustanovich I, Mechoulam R.

Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3662-5. Epub 2001 Mar 20.

50.

A historical overview of chemical research on cannabinoids.

Mechoulam R, Hanus L.

Chem Phys Lipids. 2000 Nov;108(1-2):1-13. Review.

PMID:
11106779

Supplemental Content

Support Center